ScholarIQanswers from OpenAlex

Artificial intelligence-based plasma exosome label-free SERS profiling strategy for early lung cancer detection

PaperCitations, authors & open-access status

Artificial intelligence-based plasma exosome label-free SERS profiling strategy for early lung cancer detection is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Artificial intelligence-based plasma exosome label-free SERS profiling strategy for early lung cancer detection have?

ScholarIQcitation count

Artificial intelligence-based plasma exosome label-free SERS profiling strategy for early lung cancer detection has 37 citations in the OpenAlex counts ScholarIQ stores.

When was Artificial intelligence-based plasma exosome label-free SERS profiling strategy for early lung cancer detection published?

ScholarIQyear

Artificial intelligence-based plasma exosome label-free SERS profiling strategy for early lung cancer detection has 2024 year in the ScholarIQ index.

What is the open-access status of Artificial intelligence-based plasma exosome label-free SERS profiling strategy for early lung cancer detection?

ScholarIQoa status

Artificial intelligence-based plasma exosome label-free SERS profiling strategy for early lung cancer detection has closed oa status in the ScholarIQ index.

What is the DOI of Artificial intelligence-based plasma exosome label-free SERS profiling strategy for early lung cancer detection?

ScholarIQdoi

The DOI for Artificial intelligence-based plasma exosome label-free SERS profiling strategy for early lung cancer detection is on the source record.

What is the PMID of Artificial intelligence-based plasma exosome label-free SERS profiling strategy for early lung cancer detection?

ScholarIQpmid

The PMID for Artificial intelligence-based plasma exosome label-free SERS profiling strategy for early lung cancer detection is on the source record.

What is the OpenAlex record for Artificial intelligence-based plasma exosome label-free SERS profiling strategy for early lung cancer detection?

ScholarIQopenalex

The OpenAlex for Artificial intelligence-based plasma exosome label-free SERS profiling strategy for early lung cancer detection is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial